The latest financial statement is for the quarter ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Fair value gain on derivative liability | 0 | 0 | - |
| Foreign exchange effect on convertible debenture | 0 | 0 | - |
| Issuance of shares for advisory units | 0 | - | - |
| Provision for contract settlement | 0 | - | - |
| Provision for losses on related party transactions | - | 0 | 0 |
| Provision for legal claim | 0 | - | - |
| Depreciation | 24,514 | 22,503 | 23,391 |
| Interest due from related parties loan | 792 | 793 | 784 |
| Provision for legal claim | 237,756 | 231,164 | 223,089 |
| Restricted shares units | -1,165,008 | -2,248,861 | 113,638 |
| Share based payments | 1,111,203 | 3,668,475 | 557,003 |
| Accounts payable and accrued liabilities | 1,578,598 | -656,214 | 212,509 |
| Accounts receivable | -132,700 | 96,700 | 200,000 |
| Contract assets and unbilled revenue | 0 | 0 | -6,654 |
| Deferred financing costs | 0 | -33,151 | -85,395 |
| Deferred revenue | 0 | 0 | -100,000 |
| Prepaid expenses | -109,986 | 600,059 | -20,348 |
| Provision for contract settlement | - | 0 | 0 |
| Tax receivable | 33,769 | 38,990 | 84,291 |
| Net loss | -5,476,661 | -9,867,058 | -9,638,843 |
| Issuance of shares for services | - | 0 | 0 |
| Accretion expense | 3,155 | 0 | 0 |
| Interest expense | 13,037 | 7,278 | 4,976 |
| Net cash used in operating activities | -3,465,281 | -9,546,104 | -8,776,915 |
| Due from related parties | - | 0 | 0 |
| Investment in equipment | 24,796 | 24,245 | 16,244 |
| Net cash used in investing activities | -24,796 | -24,245 | -16,244 |
| Proceeds from issuance of special warrants | 0 | 0 | 0 |
| Special warrant issuance costs | 0 | - | - |
| Deferred grant | 41,739 | -17,832 | -49,900 |
| Proceeds from issuance of contingent consideration | 495,880 | - | - |
| Special warrant issuance costs | - | 0 | 0 |
| Contingent consideration issuance costs | 50,037 | - | - |
| Proceeds from issuance of convertible debentures | 1,934,170 | 0 | 0 |
| Private placement issuance costs | - | 941,722 | 818,073 |
| Convertible debentures issuance costs | 69,527 | - | - |
| Proceeds from issuance of units | 0 | 7,000,332 | 7,929,900 |
| Units issuance costs | 1,759,795 | - | - |
| Proceeds from issuance of equity instruments | 0 | 1,572,440 | 0 |
| Repayments of loans | 0 | 1,938 | 0 |
| Net cash provided by financing activities | 2,352,225 | 7,611,280 | 7,061,927 |
| Foreign exchange effect on cash | -4,102 | -87,018 | 170,321 |
| Net change in cash during the period | -1,141,954 | -2,046,087 | -1,560,911 |
| Cash and cash equivalents at beginning of period | - | 4,816,906 | - |
| Cash and cash equivalents at end of period | - | 1,209,908 | - |
Verses AI Inc. (VRSSF)
Verses AI Inc. (VRSSF)